Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People over 18 years old, both male and female
- People who have had an acute stroke caused by a blockage in specific blood vessels in the brain (the internal carotid artery, a major brain artery called the middle cerebral artery, or both)
- People who have undergone a procedure to physically remove the blood clot causing the stroke (called endovascular thrombectomy)
- People whose blocked blood vessel was successfully reopened during that procedure, based on a specific medical scoring measure (confirm with trial site)
- People who are able to give written consent to participate, or — if they are unable to do so — whose family member has provided written authorisation. Non-English-speaking patients must have access to a person with sufficient German language ability to act as a translator (confirm with trial site)
Who may not be able to join:
- People who have previously stated or documented that they do not wish to take part in any scientific research study
- People who have medical reasons that prevent them from having an MRI scan, such as a pacemaker, certain metal implants or tattoo dyes, glaucoma, or confirmed pregnancy, or who are unable to cooperate with breathing instructions during the scan
- People who have serious heart or lung conditions, such as severe uncontrolled asthma, advanced chronic obstructive lung disease, widespread lung tissue disease, a blood clot in the lungs, a recent heart attack, or severe heart failure
- People who have dangerously high pressure inside the skull at the time of the trial
- People who have a significant level of bleeding in the brain following their stroke, as measured by a specific medical classification system (confirm with trial site)
- People who have had a new seizure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jorn Fierstra, Prof Dr. med., PhD, University of Zurich
Phone: 43 253 90 19
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of the BOLD-CVR signal with the functional outcome at 3 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.